乳腺MRI作为BI-RADS 3类和4类微钙化评估的问题解决工具:是否值得进行?
研究纳入138例女性146处BI-RADS 3类和4类微钙化,评估问题解决性乳腺MRI的价值。MRI较乳腺X线摄影将阳性预测值从43%提高到68%、特异度从80%提高到93%(P=.054和.005)。MRI有可能改善3类或4类微钙化的诊断并改变活检指征。
要点
- MRI将BI-RADS 3类和4类微钙化的阳性预测值从43%提高到68%,特异度从80%提高到93%。
- 44处4类微钙化中MRI正确诊断77%(34/44),乳腺X线摄影为43%(19/44),80%(20/25)的不必要活检可被避免。
- 24例癌中5例MRI阴性,MRI阴性癌为低级别(导管原位癌或浸润性)的可能性显著更高(P=.0362)。
核心结论
- 乳腺MRI有潜力改善3类或4类微钙化的诊断,并可能改变活检指征。
- 乳腺MRI可能有助于预测3类或4类微钙化中是否存在更高级别癌。
研究设计与样本
- 研究纳入2010年1月1日至2011年12月31日期间138例女性146处BI-RADS 3类和4类微钙化(无超声对应发现),行乳腺MRI并以11G针立体定向空心针活检或至少24个月随访为参考。
- 以BI-RADS分类1-3类为良性、4类和5类为恶性计算阳性预测值、阴性预测值、敏感度和特异度。
诊断标准与关键数值
- 146处微钙化中24例(16.4%)为恶性(18例导管原位癌,6例浸润性)。
- MRI较乳腺X线摄影将阳性预测值从43%提高到68%(P=.054),特异度从80%提高到93%(P=.005)。
- 102处3类微钙化中,MRI将5例癌正确评估为4类。
- 44处4类微钙化中,MRI正确诊断77%(34/44),乳腺X线摄影为43%(19/44),80%(20/25)的不必要活检可被避免。
- 24例癌中5例MRI阴性,MRI阴性癌为低级别(导管原位癌或浸润性)的可能性显著更高(P=.0362)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: We aimed to investigate the utility of problem-solving breast magnetic resonance imaging (MRI) for mammographic Breast Imaging Reporting and Data System (BI-RADS) categories 3 and 4 microcalcifications.
MATERIALS AND METHODS: Between January 1, 2010 and December 31, 2011, 138 women with 146 areas of categories 3 and 4 microcalcifications without sonographic correlates underwent breast MRI and had a stereotactic core biopsy using an 11-gauge needle or follow-up at least for 24 months. Positive predictive value (PPV), negative predictive value, sensitivity, and specificity were calculated on the basis of BI-RADS category, with categories 1-3 being considered benign and categories 4 and 5 being considered malignant.
RESULTS: Twenty-four cases (16.4%) were malignant (18 ductal carcinoma in situ, 6 invasive). MRI increased PPV and specificity from 43% to 68% and from 80% to 93% (P = .054 and .005) compared to mammography. Within 102 category 3 microcalcifications, 5 carcinomas were assessed correctly as category 4 by MRI. Within 44 category 4 microcalcifications, a correct diagnosis was made by MRI in 77% (34 of 44) as opposed to 43% (19 of 44) by mammography, and 80% (20 of 25) of unnecessary biopsies could have been avoided. Within the 24 carcinomas, 5 were negative at MRI. MRI-negative carcinomas have a significantly higher possibility of being low grade (ductal carcinoma in situ or invasive) (P = .0362).
CONCLUSIONS: Breast MRI has the potential to improve the diagnosis of category 3 or 4 microcalcifications and could alter indications for biopsy. Breast MRI could help predict the presence or absence of higher-grade carcinoma for category 3 or 4 microcalcifications.
引用
- Shimauchi A, Machida Y, Maeda I, et al. Breast MRI as a Problem-solving Study in the Evaluation of BI-RADS Categories 3 and 4 Microcalcifications: Is it Worth Performing? Acad Radiol. 2017. PMID: 29191685. doi:10.1016/j.acra.2017.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。